440
Participants
Start Date
July 19, 2016
Primary Completion Date
March 3, 2020
Study Completion Date
March 3, 2020
Hydroxyurea (Moderate Dose)
The study intervention will include moderate dose hydroxyurea therapy at 20 mg/kg/day (range 17.5 - 26 mg/kg/day) for 36 months.
Hydroxyurea (Low Dose)
The study intervention will include random allocation to low dose hydroxyurea therapy at 10 mg/kg/day (range 7 - 15 mg/kg/day) for 36 months.
Barau Dikko Teaching Hospital/Kaduna State University, Kaduna
Aminu Kano Teaching Hospital, Kano
Murtala Muhammad Specialist Hospital, Kano
Aminu Kano Teaching Hospital
OTHER
Murtala Muhammed Specialist Hospital
OTHER
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Barau Dikko Teaching Hospital/Kaduna State University
UNKNOWN
Vanderbilt University Medical Center
OTHER